The stock of Capricor Therapeutics Inc (CAPR) is currently priced at $7.64. In the last session, the stock climbed significantly, topping out at $77.0 after opening at $7.64. The day’s lowest price was $20.0 before the stock closed at $11.4.
The market performance of Capricor Therapeutics Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $23.40 on 10/15/24, while the lowest value for the same duration was $3.52 on 08/07/24.
52-week price history of CAPR Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Capricor Therapeutics Inc’s current trading price is -67.35% away from its 52-week high, while its distance from the 52-week low is 117.05%. The stock’s price range during this period has spanned from $3.52 to $23.40. In the Healthcare sector, the Capricor Therapeutics Inc’s shares surpassed a trading volume of approximately 19.62 million for the day, which was noticeably higher compared to the average daily volume of 9.2.62 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Capricor Therapeutics Inc (CAPR) has experienced a quarterly decline of -18.72% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 349.21M and boasts a workforce of 160 employees.
A Closer Look at Analysts’ Ratings for Capricor Therapeutics Inc
As of right now, 4 analysts are rating Capricor Therapeutics Inc as a BUY, 4 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 11.37, with a change in price of -8.31. Similarly, Capricor Therapeutics Inc recorded 2,384,217 in trading volume during the last 100 days, posting a change of -52.10%.
Examining CAPR’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for CAPR stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.03.
CAPR Stock Stochastic Average
Today’s raw stochastic average for Capricor Therapeutics Inc over the last 50 days is 17.58%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 19.85%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 50.08% and 53.41%, respectively.
CAPR Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The metric has seen a significant gain of 66.45% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -46.27%. Over the past 30 days, the price of CAPR has leaped by -45.00%. And in the last five days, it has fallen by -25.46%.
